search for




 

Human Endometrium Derived Mesenchymal Stem Cells with Aberrant NOD1 Expression Are Associated with Ectopic Endometrial Lesion Formation
International Journal of Stem Cells 2024;17:309-318
Published online August 30, 2024;  
© 2024 Korean Society for Stem Cell Research.

Chunmei Li1,2,*, Suiyu Luo1,*, Ai Guo3,*, Ying Su1, Yuhui Zhang1, Yan Song4, Mei Liu3, Lu Wang1, Yuanyuan Zhang5

1Department of Gynecology and Obstetrics, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan University People’s Hospital, Zhengzhou, China
2Department of Gynecologic Oncology, Xinxiang Key Laboratory of Gynecological Endocrinology Diagnosis and Treatment, Xinxiang Central Hospital, The Fourth Affiliated Hospital of Xinxiang Medical College, Xinxiang, China
3Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
4Department of Gynecology and Obstetrics, Women & Infants Hospital of Zhengzhou, Zhengzhou, China
5Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China
Correspondence to: Yuanyuan Zhang
Department of Gynecologic Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Panjiayuan, Chaoyang District, Beijing 100021, China
E-mail: zyyyyz026@163.com

Co-Correspondence to Lu Wang
Department of Gynecology and Obstetrics, Henan Provincial People’s Hospital, Zhengzhou University People’s Hospital, Henan University People’s Hospital, Weiwu Road, Zhengzhou 450000, Henan Province, China
E-mail: 32470810@qq.com

Co-Correspondence to Mei Liu
Laboratory of Cell and Molecular Biology & State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Panjiayuan, Chaoyang District, Beijing 100021, China
E-mail: liumei@cicams.ac.cn

*These authors contributed equally to this work.
Received December 9, 2022; Revised January 7, 2024; Accepted January 8, 2024.
This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Nucleotide-binding oligomerization domain 1 (NOD1), a cytosolic pattern recognition receptor protein, plays a crucial role in innate immune responses. However, the functional expression of NOD1 in mesenchymal stem cells (MSCs) derived from endometriosis remains unclear. The aim of this study was to explore the functions of NOD1 in ectopic endometrial lesions. Tissues and MSCs were isolated from both normal endometrium and endometriosis. Immunohistochemistry and real time quantitative polymerase chain reaction (RT-qPCR) were used to determine the expression of NOD1 in the tissues/MSCs. Quantification of various cytokines was performed using RT-qPCR and enzyme-linked immunosorbent assay. To confirm the proliferation, invasion/migration, and apoptotic viabilities of the samples, Cell Counting Kit-8, clonogenic formation, transwell assays, and apoptotic experiments were conducted. Higher levels of NOD1 expression were detected in the ectopic-MSCs obtained from endometriosis compared to those from the endometrium. The expression of interleukin-8 was higher in the ectopic-MSCs than in the eutopic-MSCs. Pretreatment with NOD1 agonist significantly enhanced the proliferation and invasion/migration of eutopic-MSCs. Additionally, the NOD1 inhibitor ML-130 significantly reduced the proliferation, clone formation, invasion, and migration abilities of the ectopic-MSCs, having no effect on their apoptosis capacity. Our findings suggest that the expression of NOD1 in ectopic-MSCs may contribute to the progression of ectopic endometrial lesions.
Keywords : Endometrium, Endometriosis, Nucleotide-binding oligomerization domain 1, Mesenchymal stem cells
Introduction

Ectopic endometrium is a common chronic inflamma-tory disorder featured by the presence of growing glands and stroma from the endometrial tissue outside the uterine cavity. Although around 90% of females experience menstrual blood reflux, only a small proportion of this population develops endometriosis (1). A previous study suggested that ectopic lesions may originate from endometrial mesenchymal stem cells (MSCs) present in retrograde menstrual blood. However, ectopic MSCs (ect-MSCs) exhibited higher rates of proliferation, clone formation, invasion, and migration compared to eutopic MSCs (eut-MSCs). Furthermore, experiments conducted on mice demonstrated that ect-MSCs could invade surrounding tissues and promote neovascularization (2).

An increasing amount of evidence has demonstrated that the activation of the local inflammatory microenvironment contributes to the formation and progression of endometriosis (3). It is well-known that innate immunity serves as the first line of defense against pathogens in mammals and can rapidly recognize conservative pathogen-associated molecular patterns through pattern recognition receptors (PRRs). Among the PRR families, nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs) are considered the primary intracellular PRRs. Notably, NOD1 and NOD2 represent crucial members of the NLR family (4). Abnormal expression of NOD1 has been impli-cated in various inflammatory diseases. In endometriosis peritoneal lavage fluid cells, increased mRNA expression of NOD1, NOD2, interleukin (IL)-1β, IL-6, IL-8, IL-10, interferon-γ, and tumor necrosis factor-α (TNF-α) was observed. Additionally, upregulated levels of NOD2 in endometrial stromal cells (ESCs) promoted the secretion of IL-6, IL-8, TNF-α, and monocyte chemoattractant protein-1 (5-7). Based on these findings, we hypothesized that NOD1 may play a role in the progression of endometriosis. Therefore, this study was aimed to investigate the differential functional expression of NOD1 between normal, eutopic, and ectopic endometrial MSCs.

Materials and Methods

Collection of tissues from normal, ectopic, and eutopic endometrium

Our study was approved by the Human Research Ethics Committee of Henan Provincial People’s Hospital (Zheng-zhou, China). Sixteen healthy females aged 32.46±5.96 years without prior medical interventions and 43 endometriosis patients aged 34.87±6.73 years were enrolled and the informed written consent was obtained. Exclusion criteria included females undergoing hormone treatment, those with abnormal uterine bleeding, submucous myoma, endometrial polyps, benign and malignant tumors, autoimmune diseases, diabetes, hypertension, and other serious systemic diseases. The ectopic and eutopic endometrium tissues were preserved in a mixture composed of 50% Dulbecco’s modified Eagle’s medium and 50% Ham’s F-12 medium (DMEM/F-12; HyClone) or fixed in 4% paraformaldehyde. A portion of the tissues was transported to the lab in DMEM/F-12, washed in phosphate buffer saline (PBS; HyClone), and used for primary cell isolation. The remaining tissues were fixed in paraformaldehyde for 24 hours and then embedded in paraffin for immunohistochemistry analysis.

Immunohistochemistry

The simplified immunohistochemistry protocol used is as follows: Paraffin sections (3 μm thick) of the ectopic and eutopic endometrium were dewaxed in xylene and ethanol, incubated in 3% hydrogen peroxide and goat serum albumin to remove endogenous peroxidase. The sections were incubated overnight with the following antibodies: 10 μg/ml rabbit anti-human vimentin, 10 μg/ml rabbit anti-human CK7, and 25 μg/ml mouse anti-human NOD1. PBS was used as a negative control. Subsequently, the sections were incubated within a moist chamber at the temperature of 4℃, followed by washing for 3 times. Next, the expression levels of proteins were determined utilizing AB complex (streptavidin/peroxidase) method (SP-9001; Zhongshanjinqiao). Color development was achieved using 3,3’-diaminobenzidine, followed by counterstaining with hematoxylin.

RNA extraction and real time quantitative pattern recognition receptor

RNA was extracted from both tissues and cells using TRIzol reagents (Invitrogen), followed by reverse transcription into cDNA using a PrimeScript RT reagent Kit (TaKaRa) in an Applied Biosystems pattern recognition receptor (PCR) machine (Applied Biosystems). The cDNA of each sample was diluted and amplified for real time quantitative PCR (RT-qPCR) in a final volume of 20 μl, containing 2 μl of the cDNA template, SYBR Premix Ex Taq II, and Rox reference dye (TaKaRa). The forward and reverse primers were purchased from Sangon Biotech. The primer pairs used for gene amplification of glyceral-dehyde-3phosphate dehydrogenase (GAPDH), NOD1, transforming growth factor-β1 (TGF-β1), vascular endothelial growth factor A (VEGFA), matrix metalloproteinase 2 (MMP2), MMP3, and IL-8 are as follow:

GAPDH: forward 5’-GCACCGTCAAGGCTGAGAAC-3’, reverse 5’-TGGTGAAGACGCCAGTGGA-3;

NOD1: forward 5’-TACTGAAAAGCAATCGGGAACT-3’, reverse 5’-GTAGAGGAAGAACTCGGACACC-3’;

TGF-β1: forward 5’-GGCCAGATCCTGTCCAAGC-3’,reverse 5’-GTGGGTTTCCACCATTAGCAC-3’;

VEGFA: forward 5’-CGGATCAAACCTCACCAAG-3’, reverse 5’-ACGCTCCAGGACTTATACC-3’,

MMP2: forward 5’-GCAATACCTGAACACCTTCTATG-3’, reverse 5’-ATTCTGGTCAAGATCACCTGTC-3’,

MMP3: forward 5’-GGTCTCTTTCACTCAGCCAACAC-3’, reverse 5’-CAGGCGGAACCGAGTCAGG-3’;

IL-8: forward 5’-ACTGAGAGTGATTGAGAGTGGAC-3’, reverse 5’-AACCCTCTGCACCCAGTTTTC-3’.

The reactions were performed at 95℃ for 30 seconds, followed by 40 cycles at 95℃ for 5 seconds and 60℃ for 30 seconds. Each sample was analyzed in triplicate using an ABI Prism 7500 Sequence Detector (Applied Biosystems). The amplified sequences were quantified against a standard curve. The expressions of the genes were normalized to that of GAPDH.

Primary cell isolation and culture

Stromal cells and MSCs were isolated from the eutopic endometrium and ectopic endometriosis tissues using collagenase II digestion (Sigma-Aldrich). The primary cells were seeded into DMEM/F-12 (Gibco) complete medium supplemented with 10% inactivated fetal bovine serum (FBS; Gibco), 100 U/ml penicillin, and 100 mg/ml streptomycin. The cells were incubated at 37℃ with 5% CO2. Non-adherent hematopoietic cells were removed by washing with PBS after 24 hours to isolate pure stromal cells. When the cells reached approximately 90% confluence, they were passaged using 0.25% Trypsin-ethylene diamine tetraacetic acid (EDTA; Gibco) at a 1:2 ratio. Differentiation studies were conducted on cells from passages 3 and 4.

Flow cytometry analysis and sorting

Stromal cells were seeded into 6-well plates until they reached 90% confluency. Subsequently, the cells were digested using 0.25% trypsin, centrifuged at 1,000 rpm for 5 minutes, and the supernatant was discarded. The cells were then washed twice with PBS and suspended in 1 ml of sheath solution. Afterwards, the cell concentration was adjusted to 1×106/ml. Next, 100 μl of the cell suspension was transferred to each tube and incubated with antibodies against CD31, CD44, CD73, CD140b, CD146, SUSD2, and CD271 for 30 minutes. Following the incubation, 500 μl of sheath solution was added. The antibody-labeled cells were subsequently analyzed and sorted using a FACSCalibur Flow Cytometer (BD Biosciences) within 1 hour. The obtained data was analyzed using FlowJo 10 software (FlowJo, LLC).

Identification of the differentiation characteristics of the MSCs

To evaluate the differentiation capacities of osteogenic, adipogenic, and chondrogenic phenotypes, three lineage differentiation detection kits (Cyagen) were utilized following the manufacturer’s instructions. The MSCs were seeded into a 24-well plate (Corning) with 500 µl of complete culture medium at a density of 5×104 cells per well. Once the cells reached 80% confluency, the complete medium was replaced with the differentiation medium. The medium was changed every 3 days over a period of 21 days. Staining with Oil Red O, Alizarin Red, and Alcian Blue dye solutions was performed to evaluate the adipocyte, osteoblast, and chondrocyte genetic capacity of the MSCs.

Clone formation assay

Cells were seeded into 6-well plates at a density of 1×103 cells per well. eut-MSCs and ect-MSCs were pretreated with various concentrations of NOD1 ligand γ-D-glutamyl-meso-diaminopimelic acid (Tri-DAP) (Invitrogen) or NOD1 inhibitor ML-130 for 10 days until obvious colony-forming unit (CFU) formation (more than fifty cells per CFU) was observed. Subsequently, the cells were fixed and stained using Giemsa’s stain (Solarbio).

Cells proliferation assay

To evaluate MSC proliferation, a cell counting assay kit (Cell Counting Kit-8, CCK-8; Tongren) and immunofluo-rescence for Ki67 were used. The CCK-8 kit utilizes a water-soluble tetrazolium salt that is reduced through cellular dehydrogenase activity to present a yellow formazan dye, in proportion to living cell number: the MSCs were seeded into 96-well plates at a density of 1×103 cells per well. eut-MSCs were pretreated with various concentrations of Tri-DAP for 72 hours, while ect-MSCs were pretreated with various concentrations of ML-130. After-ward, CCK-8 assay (10 μl) was supplemented to each well, followed by the incubation of the mixture for 2.5 hours. Subsequently, the optical density of each well was determined at 450 nm using an enzyme-linked immuno-sorbent assay (ELISA) Reader (Molecular Devices) and the number of cells were calculated. Ki67 immunofluo-rescence staining: The primary cells cultured on chamber slides were fixed using cold 4% paraformaldehyde and then permeabilized with 0.1% Triton X-100 for 15 minutes. After washing using PBS, the cells were incubated overnight with mouse anti-human Ki67 (diluted 1:200; ZSGB-BIO) as a primary antibodies, and then the slides were incubated with Alexa Fluorconjugated (green fluorescence) as secondary antibodies (Abcam) for another 1 hours at room temperature and then counter stained with 4’,6-dia-midino-2-phenylindole (blue color, P36966; Invitrogen). The stained cells were viewed using laser scanning confocal microscope (LSM780; Zeiss). The proliferative cell index was calculated as the percentage of green nucleus cells in each total cell number (green and blue nucleus staining cells).

Cell migration and invasion assays

MSCs were seeded into 12-well transwell plates (Corning) at a density of 5×104 cells in 200 μl per well and cultured with various concentrations of ML-130 (0.28 or 0.56 μM) for 24 hours. The cells on the lower membranes of the wells were then fixed and stained with Giemsa’s stain. The number of cells that had successfully migrated and invaded was calculated to analyze their migration and invasion capacities.

Cell apoptosis assay

Apoptosis Detection Kit I (BD Biosciences) was used to evaluate the ratio of apoptotic cells. The cells were seeded into 12-well plates (Corning) at a density of 1×106 cells per well and cultured with or without ML-130 for 24 and 48 hours. Cells were harvested using 0.25% trypsin without EDTA and collected with PBS into individual polystyrene round-bottom tubes 2045 (BD Falcon). Then, they were stained with Annexin-V and propidium iodide (PI) according to the manufacturer’s instructions simplified as follows: to each cell suspension, 10 μl Alexa Fluor 488-conjugated Annexin-V and 10 μl PI reagent were added. Cells were incubated in the dark for 15 minutes at room temperature. At the end of the incubation, the 400 μl binding buffer was added. Analysis was conducted using a fluorescence activated cell sorter (FACS) (FACSCalibur Flow Cytometer) as well as CellQuest software (BD Bioscie-nces). The percentage of early and late apoptotic cells was calculated using Annexin-V and PI double-positive cell staining, respectively.

Statistics

The statistical tests used in this study were identified unambiguously. The t-test with one or two tails, linear correlation in the parametric (Pearson) or non-parametric (Spearman) method were employed. Statistical analysis was carried out utilizing SPSS Statistics 19.0 software (IBM Corp.), while Prism 5.0 (GraphPad) was adopted for graph plotting. Quantitative variables between groups were compared using Student’s t-test (for normal distribution) or Mann–Whitney U-test (for non-normal distribution), and one-way or two-way ANOVA was used for multiple com-parisons. Pearson χ2 test or Fisher’s exact test was utilized to compare qualitative variables. Survival curves were generated using the Kaplan–Meier method and compared using the log-rank test. p<0.05 was considered statistically significant.

Results

Differentiation expression of NOD1 in ectopic and eutopic endometrium

To identify the ectopic and eutopic endometrium tissues, HE staining was performed (Supplementary Fig. S1A, S1E), followed by CK7 and vimentin staining to distinguish between endometrium and endometriosis. The endometrium exhibited diffuse glands in the stromal cells (Supplementary Fig. S1A-S1D), while the endometriosis primarily consisted of stromal cells (Supplementary Fig. S1E-S1H).

RT-qPCR and immunohistochemistry were employed to compare the mRNA and protein expression levels of NOD1 between ectopic and eutopic endometrium, respectively. The immunohistochemistry results demonstrated strong positive expression of NOD1 in the endometriosis (Fig. 1A-1D). Moreover, NOD1 mRNA expression was higher in the extopic endometrium (ect-EM) tissue/endometriosis with statistical significance compared to the eutopic endometrium (eut-EM) tissue/endometrium (ect-EM tissue and eut-EM tissue were paired samples and derived from the same patient) (Fig. 1E). Notably, for patients with endometriosis, NOD1 expression in their eut-EM tissue did not differ significantly from that observed in the endometrium (EN) from healthy females (Fig. 1E, EN vs. eut-EM, p=0.738).

Figure 1. Expression of nucleotide-binding oligomerization domain 1 (NOD1) in endometrium (EN) and endometriosis. HE staining identified eutopic (A, 40×) and ectopic (C, 40×) endometrium morphology. Both eutopic (n=5) and ectopic (n=6) endometrium tissues expressed NOD1 (B and D, 40×). NOD1 mRNA expression level in endometrium from healthy donor (EN) and endometriosis (Fig. 1 EN and endometriosis); ectopic-endometrium (ect-EM) and eutopic-endometrium (eut-EM) were compared to the tissues from patients with endometriosis. ect-EM represents endometriosis and eut-EM represents the normal EN from the same patient. EN, n=16; endometriosis, n=41; eut-EM and paired ect-EM, n=11.

To explore whether and how NOD1 is functionally expressed in MSC-assisted endometrial ectopic implants, MSCs were isolated from the endometrial and endometriosis tissues. Adherent eutopic and ectopic ESCs were grown (Supplementary Fig. S2A, S2C). CD45(−) & CD31(−) & CD44(+) stromal cells were selected as MSCs, achieving a purity of approximately 98% after 72 hours of culture (Supplementary Fig. S2B, S2D). The eut-MSCs and ect-MSCs exhibited spindle-shaped or short and conical morphology. Adipogenic, osteogenic, and chondrogenic differentiation successfully induced multilineage differentiation potential of CD44(+) MSCs. Immunostaining revealed the presence of NOD1 protein in both CD44(+) eut-MSCs and ect-MSCs (Fig. 2A, 2B). Additionally, an increasing trend was observed in NOD1 mRNA expression among the ect-MSCs, although the trend was not statistically significant (Fig. 2C).

Figure 2. Expression of nucleotide-binding oligomerization domain 1 (NOD1) in endometrium (EN) and endometriosis. HE staining identified eutopic (A, 40×) and ectopic (C, 40×) endometrium morphology. Both eutopic (n=5) and ectopic (n=6) endometrium tissues expressed NOD1 (B and D, 40×). NOD1 mRNA expression level in endometrium from healthy donor (EN) and endometriosis (Fig. 1 EN and endometriosis); ectopic-endometrium (ect-EM) and eutopic-endometrium (eut-EM) were compared to the tissues from patients with endometriosis. ect-EM represents endometriosis and eut-EM represents the normal EN from the same patient. EN, n=16; endometriosis, n=41; eut-EM and paired ect-EM, n=11.

High NOD1 expression functionally affects the viability of eut-MSCs

Stimulation with the various concentration of NOD1 ligand, Tri-DAP, increased the number of CFUs and the proliferation of eut-MSCs (Fig. 3A, 3B), which was consistent with their increased viability and proliferation rates in Ki67 assays (Fig. 3C). The significantly higher proportion of proliferative cells were observed in the proliferation phase compared to the control cells (pretreated with PBS).

Figure 3. Nucleotide-binding oligomerization domain 1 (NOD1)high expression up-regulated the proliferation of eutopic mesenchymal stem cells (eut-MSCs). (A) colony-forming units (CFUs) of ectopic MSCs (ect-MSCs) following pretreatments by various Tri-DAP concentration gradient (0, 1, 10, and 100 ng/ml) (n=3). (B, C) Higher expression of NOD1 induced proliferation of eut-MSCs (one representative picture from three patients). The stimulation of Tri-DAP concentration gradient was 0, 1, 10, 100 ng/ml, and 1 μg/m (reproducible for 3 times). (B) A commercial cell enumeration kit (Cell Counting Kit-8, CCK-8) was used to analyze eut-MSCs growth, OD.450 value presented the activity of cells proliferative capacity. (C) Nucleus of cells stained with 4’,6-diamidino-2-phenylindole (blue color) and while proliferation cells were valued by Ki67 staining (green fluorescence). (D) The transcription levels of interleukin (IL)-8 in eut-MSCs (n=5) and ect-MSCs group (n=4).

Since MSCs originating from endometrial tissue are implanted outside the uterine cavity, they need to tolerate the local microenvironment properly. To explore the differences in chemokine/cytokine profiles between eut-MSCs and ect-MSCs, we measured the transcription levels of IL-8 (Fig. 3D). The ect-MSC samples exhibited significantly higher IL-8 expression compared to the eut-MSC group (p<0.05). Moreover, the ect-MSC samples also performed significantly enhanced migratory capacity compared to the eut-MSC group (Supplementary Fig. S3) (p<0.0001).

Partial decrease in viability of ect-MSCs by ML-130

After pretreatment with ML-130, the inhibitory effect on ect-MSCs was evaluated at 24, 48, and 72 hours. Nota-bly, after 48 hours, the proliferation of ect-MSCs was significantly inhibited (Fig. 4A, right panel). In addition, clonogenesis, invasion, and migration abilities decreased following ML-130 pretreatment, as shown in Fig. 4A left panel and 4B. The transcription and secretion levels of IL-8 were higher in the ect-MSCs group with statistical significance compared to the eut-MSCs group (Fig. 4C, 4D). However, ML-130 pretreatment partially inhibited the upregulated expression of IL-8 (Fig. 4C, 4D).

Figure 4. ML-130 affected the bio-habits of ectopic mesenchymal stem cells (ect-MSCs). ect-MSCs were stimulated by different concentrations of ML-130 (0, 0.28, and 0.56 μM) at different time points. (A) Colony-forming units (CFUs) decreased with the increase of ML-130 concentration at 48 hours (left panels). The proliferative effects of various concentration gradient of ML-130 on ect-MSCs (n=3) at 48 hours (right panel). (B) The invasion and migration capacities of ect-MSCs were significantly inhibited by the ML-130 at 0.28 and 0.56 μM (n=4) (left panels 200×, the number of invasion and migration cells per field); The transcription (C) and secretion levels (D) of interleukin (IL)-8 of ect-MSCs pretreated with ML-130 (n=4 in each group). **p<0.01.

Stimulation of primary ect-MSCs by ML-130 affects cell apoptosis

Primary ect-MSCs were stimulated with varying concentrations (0, 0.28, or 0.56 μM) of ML-130 for a duration of 48 hours (Fig. 5). Although there was a noticeable trend towards early apoptosis in the ect-MSCs, the observed difference between pretreatment cells and control cells were not statistically significant (Fig. 5B-5E) (p>0.05).

Figure 5. Apoptotic percentage of ectopic mesenchymal stem cells (ect-MSCs) with nucleotide-binding oligomerization domain 1 (NOD1) down-regulation. After pretreated with various concentration of ML-130 (0, 0.28, and 0.56 μM) for 48 hours, respectively, the apoptotic ratio was measured by flow cytometry (A); (B-E) The percentage of sub-population of cells. The apoptotic ratio was measured by flow cytometry (propidium iodide [PI]-phycoerythrin [PE] and Annexin V-FITC). PI(+) & Annexin(–) presents necrotic cells debris (B), PI(+) & Annexin(+) presents late apoptotic cells (C), PI(−) & Annexin(+) presents early apoptotic cells (D), PI(−) & Annexin(−) presents live cells/normal cells (E). Representative results of ectopic mesenchymal stem cells from 5 patients.
Discussion

NOD1, the first intracellular PRR identified in the NOD-like receptor family, is capable of recognizing degradation products of bacterial cell wall peptide glycans. It plays a crucial role in promoting the release of proinflammatory factors and participating in the innate immune response. Our study discovered higher mRNA expression levels of NOD1 in the ect-EM group compared to the eut-EM group. The components of the ect-EM need to tolerate their microenvironment. Previous research has demonstrated that the proliferation and invasion of ectopic ESCs (ect-ESCs) are promoted by MMP2 and MMP9, leading to the formation of ectopic lesions (8). Overexpre-ssion of VEGFA in ect-ESCs enhances their invasive and migratory capabilities. However, inhibiting VEGFA expression can counteract these effects. Placental and fetal membrane expression of NOD1 stimulates the secretion of IL-1 and IL-6 through activation of the RIP2-NF-κB/MAPK signaling pathway (9). Our study revealed that NOD1 could upregulate the IL-8 secretion level in cervical cancer cells (10). Other studies have reported higher levels of IL-8 secretion by peritoneal macrophages from patients with endometriosis (11). Elevated IL-8 expression is implicated in the adhesion and implantation of ectopic lesions (12, 13). Moreover, our findings demonstrated signi-ficantly higher IL-8 mRNA expression in ect-MSCs compared to eut-MSCs, suggesting that abnormal IL-8 expre-ssion in ect-MSCs may contribute to the development of ectopic endometriosis. Notably, ML-130, an inhibitor of NOD1, can partial decrease IL-8 upregulation and may functionally inhibit the formation of endometriosis in vitro.

Studies have identified elevated NOD1 expression at the mRNA level in endometriosis peritoneal lavage fluid cells (14). Our study focused on NOD1 expression in ect-MSCs obtained from endometriosis patients. The high expression of NOD1 in these ect-MSCs suggests their involvement in the development of ectopic endometriosis. Chlamydia trachomatis infection in vivo relies on NOD1-RIP2 to induce IL-8 expression, which contributes to the inflammatory reaction (15). Navarro et al. (16) demonstrated that NOD1 agonist induced the expressions of IL-6 and IL-8 in cerebral pericytes, thus promoting a perivascular inflammatory reaction through the NOD1-p38MAPK/NF-κB-IL-8 signaling pathway.

MMP2 and MMP3 can hydrolyze various components of the extracellular matrix and basement membranes such as fibronectin, laminin, collagen IV, and gelatin. This hydrolysis can result in the disruption of the basement membrane and extracellular matrix, allowing the eutopic endometrium to breach the local barrier and promote the ectopic growth of adjacent tissues (17, 18). Multiple studies have reported higher expression of MMP3 in eutopic endometrium compared to normal endometrium. Muharam et al. (19) detected down-regulated levels of MMP3 expression in normal endometrium tissues than in eutopic endometrium, while Luddi et al. (17) found lower expression of MMP3 in endometrium. Our study was not consistent with above findings, revealing significantly higher transcription levels of MMP2 and MMP3 in eut-MSCs compared to ect-MSCs (data was not shown). This difference may be attributed to the fact that most participants in our study were in the proliferative phase with low progesterone levels, which can inhibit the expression of MMPs in the endometrium (20).

Furthermore, we investigated the impact of NOD1 expression on the invasion and migration abilities of ect-MSCs. Our findings indicated that ML-130 partially hindered the invasion and migration abilities of ect-MSCs, suggesting the involvement of NOD1 in their invasion and migration. The development of ectopic lesions relies on an imbalance between the expression levels of pro-apoptotic and anti-apoptotic genes in ESCs (21). Delbandi et al. (22) discovered that the apoptotic ability of ectopic ESCs was lower compared to eutopic ESCs. Previous research has indicated that NOD1, a pro-apoptotic protein, can induce apoptosis by interacting with caspase or apaf1, while NF-κB inhibits apoptosis. NOD proteins can activate both NF-κB and caspase signaling pathways (23). Nevertheless, in our study, the apoptosis rate of the ect-MSCs was not determined along with the inhibition of NOD1 expression. Liu et al. (24) found that ect-MSCs exhibited a higher level of proliferation, while Burlev et al. (25) observed no difference in the proliferation abilities between ect-MSCs and eut-MSCs. Overall, our study uncovered that the NOD1 ligand Tri-DAP can promote the proliferation of eut-MSCs. Conversely, ML-130 inhibits the proliferation and migration/invasion of ect-MSCs. However, further exploration is required to elucidate the underlying signaling pathway.

Supplementary Materials

Supplementary data including three figures can be found with this article online at https://doi.org/10.15283/ijsc22200

Potential Conflict of Interest

There is no potential conflict of interest to declare.

Data Availability Statement

The original data of the study can be provided by the correspondence author upon reasonable request.

Authors’ Contribution

Conceptualization: Yuanyuan Zhang, LW. Data curation: SL, ML. Formal analysis: CL, Yan Song. Funding acquisition: Yuanyuan Zhang, LW, SL. Investigation: CL, AG. Methodology: Yuanyuan Zhang, Yuhui Zhang. Project administration: Yuanyuan Zhang, SL. Resources: Ying Su. Software: CL, Yuanyuan Zhang. Supervision: ML, Yuanyuan Zhang. Validation: Yuanyuan Zhang, LW. Visualization: CL, ML. Writing – original draft: Yuanyuan Zhang, CL. Writing – review and editing: LW, Yuanyuan Zhang.

Funding

This work was supported by the National Natural Science Foundation of China (81601261, 82173333), Henan Pro-vince Medical Science and Technology Project (LHGJ20190596), and Science and Technology Development Plan (202102310066).

References
  1. Cook CJ, Wiggin N, Fogg KC. Characterizing the extracellular matrix transcriptome of endometriosis. Reprod Sci 2024;31:413-429.
    Pubmed KoreaMed CrossRef
  2. Kao AP, Wang KH, Chang CC, et al. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 2011;95:1308-1315.e1.
    Pubmed CrossRef
  3. Patel BG, Lenk EE, Lebovic DI, Shu Y, Yu J, Taylor RN. Pathogenesis of endometriosis: interaction between endocrine and inflammatory pathways. Best Pract Res Clin Obstet Gynaecol 2018;50:50-60.
    Pubmed CrossRef
  4. Pei G, Dorhoi A. NOD-like receptors: guards of cellular homeostasis perturbation during infection. Int J Mol Sci 2021;22:6714.
    Pubmed KoreaMed CrossRef
  5. Zhang Y, Zhang Y, Li C, et al. NOD1 modulates decidual stromal cell function to maintain pregnancy in the early trimester. Cell Biochem Funct 2019;37:464-473.
    Pubmed CrossRef
  6. King AE, Horne AW, Hombach-Klonisch S, Mason JI, Critchley HO. Differential expression and regulation of nuclear oligomerization domain proteins NOD1 and NOD2 in human endometrium: a potential role in innate immune protection and menstruation. Mol Hum Reprod 2009;15:311-319.
    Pubmed CrossRef
  7. Zhang Y, Yang C, Fu S, et al. Different expression of NOD2 in decidual stromal cells between normal and unexplained recurrent spontaneous abortion women during first trimester gestation. Int J Clin Exp Pathol 2014;7:8784-8790.
    Pubmed KoreaMed
  8. Diao R, Wei W, Zhao J, Tian F, Cai X, Duan YG. CCL19/CCR7 contributes to the pathogenesis of endometriosis via PI3K/Akt pathway by regulating the proliferation and invasion of ESCs. Am J Reprod Immunol. 2017;78:e12744.
    Pubmed CrossRef
  9. Zhu L, Wang Y, Zhu Y, Zhang W, Zhu J. Expression of NOD1 and downstream factors in placenta, fetal membrane and plasma from pregnancies with premature rupture of membranes and their significance. Int J Clin Exp Pathol 2018;11:5745-5754.
    Pubmed KoreaMed
  10. Zhang Y, Li N, Yuan G, et al. Upregulation of NOD1 and NOD2 contribute to cancer progression through the positive regulation of tumorigenicity and metastasis in human squamous cervical cancer. BMC Med 2022;20:55.
    Pubmed KoreaMed CrossRef
  11. Rahmawati NY, Ahsan F, Santoso B, et al. IL-8 and IL-12p70 are associated with pelvic pain among infertile women with endometriosis. Pain Med 2023;24:1262-1269.
    Pubmed CrossRef
  12. Crispim PCA, Jammal MP, Murta EFC, Nomelini RS. Endometriosis: what is the influence of immune cells? Immunol Invest 2021;50:372-388.
    Pubmed CrossRef
  13. Ramírez-Pavez TN, Martínez-Esparza M, Ruiz-Alcaraz AJ, Marín-Sánchez P, Machado-Linde F, García-Peñarrubia P. The role of peritoneal macrophages in endometriosis. Int J Mol Sci. 2021;22:10792.
    Pubmed KoreaMed CrossRef
  14. Guo B, Chen JH, Zhang JH, et al. Pattern-recognition receptors in endometriosis: a narrative review. Front Immu-nol. 2023;14:1161606.
    Pubmed KoreaMed CrossRef
  15. Buchholz KR, Stephens RS. The cytosolic pattern recognition receptor NOD1 induces inflammatory interleukin-8 during Chlamydia trachomatis infection. Infect Immun 2008;76:3150-3155.
    Pubmed KoreaMed CrossRef
  16. Navarro R, Delgado-Wicke P, Nuñez-Prado N, et al. Role of nucleotide-binding oligomerization domain 1 (NOD1) in pericyte-mediated vascular inflammation. J Cell Mol Med 2016;20:980-986.
    Pubmed KoreaMed CrossRef
  17. Luddi A, Marrocco C, Governini L, et al. Expression of matrix metalloproteinases and their inhibitors in endometrium: high levels in endometriotic lesions. Int J Mol Sci 2020;21:2840.
    Pubmed KoreaMed CrossRef
  18. Yang H, Liu J, Fan Y, et al. Associations between various possible promoter polymorphisms of MMPs genes and endometriosis risk: a meta-analysis. Eur J Obstet Gynecol Reprod Biol 2016;205:174-188.
    Pubmed CrossRef
  19. Muharam R, Rahmala Febri R, Mutia K, et al. Down-regulation of miR-93 negatively correlates with overexpression of VEGFA and MMP3 in endometriosis: a cross-sectional study. Int J Fertil Steril 2023;17:28-33.
    Pubmed KoreaMed CrossRef
  20. Bruner-Tran KL, Eisenberg E, Yeaman GR, Anderson TA, McBean J, Osteen KG. Steroid and cytokine regulation of matrix metalloproteinase expression in endometriosis and the establishment of experimental endometriosis in nude mice. J Clin Endocrinol Metab 2002;87:4782-4791.
    Pubmed CrossRef
  21. Baranov VS, Ivaschenko TE, Liehr T, Yarmolinskaya MI. Systems genetics view of endometriosis: a common complex disorder. Eur J Obstet Gynecol Reprod Biol 2015;185:59-65.
    Pubmed CrossRef
  22. Delbandi AA, Mahmoudi M, Shervin A, Heidari S, Kola-hdouz-Mohammadi R, Zarnani AH. Evaluation of apoptosis and angiogenesis in ectopic and eutopic stromal cells of patients with endometriosis compared to non-endometriotic controls. BMC Womens Health 2020;20:3.
    Pubmed KoreaMed CrossRef
  23. Kasimsetty SG, Hawkes A, Barekatain K, Soo E, Welch AK, McKay DB. TLR2 and NODs1 and 2 cooperate in inflammatory responses associated with renal ischemia reperfusion injury. Transpl Immunol. 2020;58:101260.
    Pubmed KoreaMed CrossRef
  24. Liu H, Zhang W, Wang L, et al. GLI1 is increased in ovarian endometriosis and regulates migration, invasion and proliferation of human endometrial stromal cells in endo-metriosis. Ann Transl Med 2019;7:663.
    Pubmed KoreaMed CrossRef
  25. Burlev VA, Pavlovich SV, Il’yasova NA. Apoptosis and proliferative activity in endometrium during peritoneal endo-metriosis. Bull Exp Biol Med 2006;141:204-217.
    Pubmed CrossRef


November 2024, 17 (4)
Full Text(PDF) Free
Supplementary File

Social Network Service

Services

Cited By Articles
CrossRef (0)